GANDEEVA
Live / Applied — Statement of use — registration review complete (as of 29 Mar 2026)
What this means for you
Not registered yet, but its 26 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97981256
- Mark type
- Stylized text
- Filed
- 26 Jul 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; Scientific research; Medical oncology research; Scientific study and research in the fields of protein interactions and aberrant protein function; Biological research and analysis; Providing medical and scientific research information; Providing information about medical research via a website; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of structural biology, artificial intelligence and machine learning; Software as a service (SaaS) services featuring software for bioinformatics data analysis; Pharmaceutical drug development services; Biochemical research and analysis; Providing information in the field of drug discovery via a website; Providing information in the field of structural biology via a website
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of oncology; Providing medical information in the field of protein interactions and aberrant protein function; Providing pharmaceutical information; Medical analysis services for diagnostic and treatment purposes; Providing information in the field of medicine via a website; Providing information in the field of oncology via a website; providing information and commentary in the field of precision medicine
Owner
- Gandeeva Therapeutics, Inc., Seattle, WA, US
- Gandeeva Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 29 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Sept 2025 — USE AMENDMENT FILED
- 05 Mar 2026 — DIVISIONAL PROCESSING COMPLETE
- 26 Sept 2025 — DIVISIONAL REQUEST RECEIVED
- 05 Mar 2026 — SOU EXTENSION 5 GRANTED
- 26 Sept 2025 — SOU EXTENSION 5 FILED
- 04 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 4 GRANTED
- 26 Sept 2025 — SOU EXTENSION 4 FILED
- 26 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 26 Sept 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 26 Sept 2025 — SOU TEAS EXTENSION RECEIVED